K. Plaschke et al., The neuroprotective effect of cerebral poly(ADP-ribose) polymerase inhibition in a rat model of global ischemia, NEUROSCI L, 284(1-2), 2000, pp. 109-112
In the present study, the effect of poly(ADP-ribose) polymerase (PARP) inhi
bition on rat cortical energy state was investigated at 24 h after global c
erebral ischemia induced by permanent bilateral common carotid artery ligat
ion plus transient hypotension. The specific PARP inhibitor 3-aminobenzamid
e was injected 10 min before induction of ischemia at a dosage of 5, 10, an
d 20 mg/kg intracerebroventricularly. Twenty-four hours after ischemia cort
ical PARP enzyme activity increased from 0.425 +/- 0.144 to 0.794 +/- 0.193
units/mg protein. Cerebral ischemia was associated by a decrease in adenos
ine triphosphate (ATP) and phosphocreatine concentrations to 72.5 and 76.8%
of controls, respectively. In addition, an 1.9- and 2.2-fold increase in a
denosine monophosphate and adenosine was observed. Specific PARP inhibition
with 10 mg/kg 8-aminobenzamide protected the rat energy state by preservin
g cortical phosphocreatine and NAD(+). Cortical AIP was not changed signifi
cantly after PARP inhibition. In conclusion, activation of the nuclear enzy
me PARP plays an important role in cerebral energy metabolism during rat gl
obal ischemia. Therefore, specific PARP inhibition may offer new strategies
in the therapy of vascular diseases such as stroke. (C) 2000 Elsevier Scie
nce ireland Ltd. All rights reserved.